Detection of macaque perforin expression and release by flow cytometry, immunohistochemistry, ELISA, and ELISpot

Journal of Immunological Methods

Volumn 312, Issue 1-2, 2006, Pages 45-53

  Zuber, Bartek ^a   Quigley, Máire F ^b   Critchfield, J William ^c   Shacklett, Barbara L ^c   Abel, Kristina ^d   Miller, Christopher J ^d   Mörner, Andreas ^e   Paulie, Staffan ^a   Ahlborg, Niklas ^a   Sandberg, Johan K ^b  

^a Mabtech AB   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Capture ELISA; ELISpot; Flow cytometry; Immunohistochemistry; Macaque; Monoclonal antibody; Perforin

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PF 164; MONOCLONAL ANTIBODY PF 344; MONOCLONAL ANTIBODY PF 80; NEF PROTEIN; PERFORIN; POL PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MACACA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

ANIMALS; ANTIBODIES, MONOCLONAL; CROSS REACTIONS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MACACA; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 33646928102     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.02.018     Document Type: Article

References (32)

1. Aandahl E.M., Quigley M.F., Moretto W.J., Moll M., Gonzalez V.D., Sonnerborg A., Lindback S., Hecht F.M., Deeks S.G., Rosenberg M.G., Nixon D.F., and Sandberg J.K. Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment. Blood 104 (2004) 3672
2. Andersson J., Behbahani H., Lieberman J., Connick E., Landay A., Patterson B., Sönnerborg A., Lore K., Uccini S., and Fehniger T.E. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. Aids 13 (1999) 1295
3. Appay V., Nixon D.F., Donahoe S.M., Gillespie G.M., Dong T., King A., Ogg G.S., Spiegel H.M., Conlon C., Spina C.A., Havlir D.V., Richman D.D., Waters A., Easterbrook P., McMichael A.J., and Rowland-Jones S.L. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192 (2000) 63
4. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., Ogg G.S., King A., Lechner F., Spina C.A., Little S., Havlir D.V., Richman D.D., Gruener N., Pape G., Waters A., Easterbrook P., Salio M., Cerundolo V., McMichael A.J., and Rowland-Jones S.L. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8 (2002) 379
5. Appay V., Zaunders J.J., Papagno L., Sutton J., Jaramillo A., Waters A., Easterbrook P., Grey P., Smith D., McMichael A.J., Cooper D.A., Rowland-Jones S.L., and Kelleher A.D. Characterization of CD4(+) CTLs ex vivo. J. Immunol. 168 (2002) 5954
6. Badovinac V.P., Hamilton S.E., and Harty J.T. Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity 18 (2003) 463
7. Beattie T., Kaul R., Rostron T., Dong T., Easterbrook P., Jaoko W., Kimani J., Plummer F., McMichael A., and Rowland-Jones S. Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes. Aids 18 (2004) 1595
8. Betts M.R., Price D.A., Brenchley J.M., Lore K., Guenaga F.J., Smed-Sorensen A., Ambrozak D.R., Migueles S.A., Connors M., Roederer M., Douek D.C., and Koup R.A. The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration. J. Immunol. 172 (2004) 6407
9. Betts M.R., Exley B., Price D.A., Bansal A., Camacho Z.T., Teaberry V., West S.M., Ambrozak D.R., Tomaras G., Roederer M., Kilby J.M., Tartaglia J., Belshe R., Gao F., Douek D.C., Weinhold K.J., Koup R.A., Goepfert P., and Ferrari G. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4512
10. Cebere I., Dorrell L., McShane H., Simmons A., McCormack S., Schmidt C., Smith C., Brooks M., Roberts J.E., Darwin S.C., Fast P.E., Conlon C., Rowland-Jones S., McMichael A.J., and Hanke T. Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers. Vaccine (2005)
11. Champagne P., Ogg G.S., King A.S., Knabenhans C., Ellefsen K., Nobile M., Appay V., Rizzardi G.P., Fleury S., Lipp M., Forster R., Rowland-Jones S., Sekaly R.P., McMichael A.J., and Pantaleo G. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410 (2001) 106
12. Haigwood N.L. Predictive value of primate models for AIDS. AIDS Rev. 6 (2004) 187
13. Jordan K.A., et al. Virology 347 (2006) 117-126
14. Kaech S.M., Wherry E.J., and Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2 (2002) 251
15. Kagi D., Seiler P., Pavlovic J., Ledermann B., Burki K., Zinkernagel R.M., and Hengartner H. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25 (1995) 3256
16. Letsch A., and Scheibenbogen C. Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining. Methods 31 (2003) 143
17. Lieberman J., Shankar P., Manjunath N., and Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98 (2001) 1667
18. Makitalo B., Andersson M., Arestrom I., Karlen K., Villinger F., Ansari A., Paulie S., Thorstensson R., and Ahlborg N. ELISpot and ELISA analysis of spontaneous, mitogen-induced and antigen-specific cytokine production in cynomolgus and rhesus macaques. J. Immunol. Methods 270 (2002) 85
19. Makitalo B., Lundholm P., Hinkula J., Nilsson C., Karlen K., Morner A., Sutter G., Erfle V., Heeney J.L., Wahren B., Biberfeld G., and Thorstensson R. Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen. J. Gen. Virol. 85 (2004) 2407
20. McMichael A.J., and Hanke T. HIV vaccines 1983-2003. Nat. Med. 9 (2003) 874
21. Migueles S.A., Laborico A.C., Shupert W.L., Sabbaghian M.S., Rabin R., Hallahan C.W., Van Baarle D., Kostense S., Miedema F., McLaughlin M., Ehler L., Metcalf J., Liu S., and Connors M. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3 (2002) 1061
22. Nixon D.F., Aandahl E.M., and Sandberg J.K. New observations on CD8 cell responses. Aids 17 Suppl 4 (2003) S61
23. Norris P.J., Moffett H.F., Yang O.O., Kaufmann D.E., Clark M.J., Addo M.M., and Rosenberg E.S. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells. J. Virol. 78 (2004) 8844
24. Pantaleo G., and Koup R.A. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat. Med. 10 (2004) 806
25. Russell J.H., and Ley T.J. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20 (2002) 323
26. Sandberg J.K., Fast N.M., and Nixon D.F. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes. J. Immunol. 167 (2001) 181
27. Shacklett B.L., Cox C.A., Quigley M.F., Kreis C., Stollman N.H., Jacobson M.A., Andersson J., Sandberg J.K., and Nixon D.F. Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection. J. Immunol. 173 (2004) 641
28. Stinchcombe J., Bossi G., and Griffiths G.M. Linking albinism and immunity: the secrets of secretory lysosomes. Science 305 (2004) 55
29. Walsh C.M., Matloubian M., Liu C.C., Ueda R., Kurahara C.G., Christensen J.L., Huang M.T., Young J.D., Ahmed R., and Clark W.R. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 10854
30. Villinger F., Brar S.S., Mayne A., Chikkala N., and Ansari A.A. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155 (1995) 3946
31. Zhang D., Shankar P., Xu Z., Harnisch B., Chen G., Lange C., Lee S.J., Valdez H., Lederman M.M., and Lieberman J. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood 101 (2003) 226
32. Zuber B., Levitsky V., Jonsson G., Paulie S., Samarina A., Grundstrom S., Metkar S., Norell H., Callender G.G., Froelich C., and Ahlborg N. Detection of human perforin by ELISpot and ELISA: ex vivo identification of virus-specific cells. J. Immunol. Methods 302 (2005) 13